Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Linezolid vs. Vancomycin/Oxacillin/Dicloxacillin in the Treatment of Catheter-Related Gram-Positive Bloodstream Infections

NCT00037050 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00037050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00037050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Linezolid vs. Vancomycin/Oxacillin/Dicloxacillin in the Treatment of Catheter-Related Gram-Positive Bloodstream Infections
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2002
Completion date
July 31, 2005
Enrollment
739 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bacteremia, bacterial infections, gram-positive bacterial infections